Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 35
- Companies
Gerardo Gorostiza joins team at Linneo Health
Linneo Health has appointed Gorostiza as chief financial and strategy officer.
- Cultivation
Ananda completes first step in genetic stabilisation programme
The AQSE Growth Market listed company has now begun the self-crossing of the first generation of cannabis plants.
- Adult-Use
Broughton expands experience from nicotine into cannabinoids
Broughton CEO Chris Allen spoke to Cannabis Wealth about the company’s ambitions to support safe and effective cannabinoid delivery.
- Pharmaceutical
Agreement to carry out Phase 1 cannabinoid medicine clinical trials
Oxford Cannabinoid Technologies Holdings (OCTP) has entered into a master service agreement and work order with Simbec Research Limited.
- Companies
New medical cannabis education platform launched for Europe
The platform is currently available in the UK, Germany, France and Portugal.
- CBD Market
Spectrum Leaf products join FSA Novel Foods list
Thousands of products are included on the list, which is now closed for new applications.
- Policy & Regulation
UK white paper suggests de facto cannabis decriminalisation
A new white paper published by the UK government suggests diverting people caught with cannabis to awareness services rather than face criminal sanctions.
- Medical
AI partnership to develop personalised cannabis and CBD formulations
Kanabo Group has entered into a partnership with Pomicell Ltd, which specialises in deep-learning AI technology.
- Medical
Columbian cannabis flower reaches international market
Allied Corp has shipped its second export from the country into Europe, the US and Australia.
- Companies
Manchester cannabis company seeking to drive European growth
B3 Labs has appointed a Chief Operating Officer to drive its growth in the European cannabis market.
- Medical
New Zealand cannabis company to supply products into Europe
Medical cannabis company Cannasouth has signed a three-year supply agreement with German-based WEECO Pharma.
- CBD Market
UK Government provides educational CBD seminar
The seminar aims to provide information on CBD food supplements for those working in control laboratories, the food industry and those working in the UK official control system.
